293 related articles for article (PubMed ID: 19383908)
1. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
2. A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells.
Knight AS; Notaridou M; Watson RJ
Oncogene; 2009 Apr; 28(15):1737-47. PubMed ID: 19252525
[TBL] [Abstract][Full Text] [Related]
3. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
[TBL] [Abstract][Full Text] [Related]
4. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
5. The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.
Osterloh L; von Eyss B; Schmit F; Rein L; Hübner D; Samans B; Hauser S; Gaubatz S
EMBO J; 2007 Jan; 26(1):144-57. PubMed ID: 17159899
[TBL] [Abstract][Full Text] [Related]
6. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
7. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
8. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
9. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress.
Yao JY; Chen JK
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
Pavithra L; Singh S; Sreenath K; Chattopadhyay S
Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH
Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53.
Nandi AK; Ford T; Fleksher D; Neuman B; Rapoport AP
Biochem Biophys Res Commun; 2007 Jun; 358(1):181-8. PubMed ID: 17482142
[TBL] [Abstract][Full Text] [Related]
13. p53-Mediated transactivation of LIMK2b links actin dynamics to cell cycle checkpoint control.
Hsu FF; Lin TY; Chen JY; Shieh SY
Oncogene; 2010 May; 29(19):2864-76. PubMed ID: 20190821
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
15. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
16. Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway.
Ribeiro JC; Hanley JR; Russell PJ
Oncogene; 1996 Sep; 13(6):1269-78. PubMed ID: 8808701
[TBL] [Abstract][Full Text] [Related]
17. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
18. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
19. Gene copy number and cell cycle arrest.
Ghosh B; Bose I
Phys Biol; 2005 Dec; 3(1):29-36. PubMed ID: 16582459
[TBL] [Abstract][Full Text] [Related]
20. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
Gery S; Komatsu N; Baldjyan L; Yu A; Koo D; Koeffler HP
Mol Cell; 2006 May; 22(3):375-82. PubMed ID: 16678109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
